Deubiquitinating enzymes as oncotargets

McClurg, Urszula L ORCID: 0000-0003-2631-4174 and Robson, Craig N
(2015) Deubiquitinating enzymes as oncotargets. ONCOTARGET, 6 (12). pp. 9657-9668.

[img] Text
Deubiquitinating enzymes as oncotargets.pdf - Author Accepted Manuscript

Download (672kB)


Carcinogenesis is a complex process tightly regulated at multiple levels by post-translational modifications. Epigenetics plays a major role in cancer development, all stable changes to the gene expression process that are not a result of a direct change in the DNA code are described as epigenetics. Epigenetic processes are regulated by post-translational modifications including ubiquitination which can directly affect either histones or transcription factors or may target their co-factors and interacting partners exerting an indirect effect. Deubiquitination of these target proteins is equally important and alterations in this pathway can also lead to cancer development, progression and metastasis. Only the correct, unaltered balance between ubiquitination and deubiquitination ensures healthy cellular homeostasis. In this review we focus on the role of deubiquitinating (DUB) enzymes in various aspects of epigenetics including the regulation of transcription factors, histone modifications, DNA damage repair pathways and cell cycle regulation. We discuss the impact of those processes on tumourigenesis and potential therapeutic applications of DUBs for cancer treatment.

Item Type: Article
Uncontrolled Keywords: deubiquitination, DUBs, cancer, epigenetics, chromatin, androgen receptor, histones
Depositing User: Symplectic Admin
Date Deposited: 06 Nov 2018 12:44
Last Modified: 19 Jan 2023 01:13
DOI: 10.18632/oncotarget.3922
Related URLs: